Definitions for 29+ terms used in peptide analysis, quality testing, and laboratory science
Stability studies conducted at elevated temperature and humidity (typically 40°C/75% RH) to predict the long-term shelf life of peptides in a shortened timeframe of 3-6 months.
Stability TestingThe number of viable microorganisms present on a sample or surface. Bioburden testing confirms that peptide samples are free from bacterial, fungal, and yeast contamination.
Contaminant TestingBody Protection Compound-157: a synthetic pentadecapeptide (15 amino acids) derived from gastric juice proteins, widely studied for tissue repair and wound healing properties in research settings.
BPC-157 TestingA document issued by a testing laboratory reporting the results of analytical testing performed on a specific batch of peptide. Includes purity percentage, identity confirmation, and other quality metrics.
A Certificate of Analysis (COA) is the formal record of a peptide batch's quality. A complete COA typically includes the peptide name and sequence, lot number, manufacture and test dates, methods used, purity percentage with the corresponding HPLC chromatogram, identity confirmation with the mass spectrum, water content, counterion content, residual solvent levels, and the analyst's signature. Researchers and pharmacies should treat a COA from the manufacturer with the same skepticism as any vendor-supplied document and verify with independent third-party testing for high-stakes work.
Third-Party COA VerificationCurrent Good Manufacturing Practice. FDA regulations ensuring that products are consistently produced and controlled according to quality standards. Required for pharmaceutical peptide manufacturing.
A graphical representation of detector response versus time from an HPLC analysis. Peaks in the chromatogram correspond to different components, with the main peak representing the target peptide.
A common chemical degradation where asparagine (Asn) or glutamine (Gln) residues lose an amide group, converting to aspartic acid or glutamic acid. Detected by mass spectrometry as a +1 Da mass shift.
An impurity formed during solid-phase peptide synthesis when one or more amino acid coupling steps fail, resulting in a shorter peptide missing specific residues from the intended sequence.
A covalent bond formed between two cysteine residues in a peptide. Disulfide bonds stabilize 3D structure and are critical for biological activity. Mapping these bonds requires specialized mass spectrometry techniques.
Lipopolysaccharide (LPS) molecules from gram-negative bacteria cell walls. Endotoxin contamination in peptides is detected using the LAL (Limulus Amebocyte Lysate) assay and can cause fever and inflammation. ACS offers quantitative endotoxin testing via LAL assay alongside heavy metal and residual solvent screening.
Endotoxins are heat-stable lipopolysaccharide molecules shed by gram-negative bacteria. Even when bacteria are killed during sterilization, the endotoxin fragments remain biologically active and can trigger fever, inflammation, and septic shock if injected. The Limulus Amebocyte Lysate (LAL) assay is the FDA-recognized method to quantify endotoxin in EU/mL or EU/mg. Pharmaceutical-grade peptides intended for injection typically need to fall below regulatory thresholds based on dose and route of administration.
Endotoxin TestingElectrospray Ionization Mass Spectrometry: a soft ionization technique ideal for peptides and proteins. Produces multiply charged ions allowing analysis of large biomolecules on standard mass spectrometers.
Gas Chromatography–Mass Spectrometry, used to detect and quantify residual solvents (TFA, DMF, DCM, acetonitrile) remaining from peptide synthesis and purification processes.
Contaminant TestingA class of peptides that activate the GLP-1 receptor, used in diabetes and weight management research. Includes Semaglutide, Tirzepatide, and Retatrutide, among the most frequently tested peptides at our laboratory.
Retatrutide TestingTesamorelin TestingA quality system of management controls for research laboratories ensuring the uniformity, consistency, reliability, reproducibility, quality, and integrity of test data.
High-Performance Liquid Chromatography, an analytical technique used to separate, identify, and quantify components in a mixture. In peptide testing, HPLC is the gold standard for measuring purity by separating the target peptide from impurities.
HPLC pushes a sample through a column packed with stationary-phase particles using a high-pressure pump. As the sample travels through the column, each component interacts differently with the stationary phase and elutes at a different time. A UV detector measures absorbance and produces a chromatogram, where the area of each peak corresponds to the relative amount of each compound. For peptides, reversed-phase HPLC (RP-HPLC) with C18 columns and water/acetonitrile gradients is the standard. Purity is reported as the percentage area of the main peak relative to the total integrated area at 214 nm or 220 nm.
HPLC Purity TestingInternational Council for Harmonisation guidelines, globally recognized standards for pharmaceutical development, including analytical method validation (ICH Q2), stability testing (ICH Q1A), and impurity limits (ICH Q3).
Inductively Coupled Plasma Mass Spectrometry, used for detecting trace heavy metals (lead, mercury, arsenic, cadmium) in peptide samples at parts-per-billion sensitivity levels.
Contaminant TestingLiquid Chromatography–Tandem Mass Spectrometry, combines HPLC separation with two stages of mass analysis. Provides both purity data and structural information, enabling sequence confirmation and impurity characterization.
LC-MS/MS first separates components by HPLC, then performs two rounds of mass analysis. The first stage isolates a precursor ion, which is fragmented in a collision cell. The second stage measures the resulting fragment ions. The fragment pattern is characteristic of the peptide sequence and is used to confirm amino acid order and pinpoint the location of modifications or impurities.
Molecular AnalysisFreeze-drying process used to remove water from peptide solutions, producing a stable powder for long-term storage. Lyophilized peptides are the preferred form for shipping and analysis.
An analytical method that measures the mass-to-charge ratio of ions. Used in peptide analysis to determine molecular weight, confirm identity, and detect post-translational modifications with high accuracy.
A mass spectrometer ionizes a sample, separates the resulting ions by their mass-to-charge ratio (m/z), and measures their abundance. The output is a mass spectrum where each peak represents an ion of a specific m/z. For peptides, the observed mass is compared to the theoretical mass calculated from the amino acid sequence. A match within a few parts per million confirms identity, while mass shifts can reveal modifications like oxidation (+16 Da), deamidation (+1 Da), or truncation.
Molecular AnalysisThe process of demonstrating that an analytical method is suitable for its intended purpose. Includes testing for accuracy, precision, specificity, linearity, range, and robustness per ICH Q2 guidelines.
Chemical modification where methionine, cysteine, or tryptophan residues gain oxygen atoms. A common degradation pathway that can affect peptide activity and is detected as a +16 Da mass shift.
The self-association of peptide molecules into higher-order structures (oligomers, fibrils). Aggregation reduces bioavailability and can cause immunogenicity. Detected by dynamic light scattering (DLS) or SEC.
The percentage of the target peptide relative to total peptide content in a sample, typically measured by HPLC. Research-grade peptides usually have ≥95% purity, while pharmaceutical-grade requires ≥98%.
Peptide purity is calculated as the area of the main HPLC peak divided by the total area of all peaks, expressed as a percentage. The remaining percentage represents impurities such as deletion sequences, truncated peptides, oxidized variants, and synthesis byproducts. Purity values can vary based on the wavelength used (214 nm vs 220 nm vs 280 nm) and the detection method. Independent verification is the only way to confirm a supplier's purity claim.
HPLC Purity TestingChemical changes to amino acid residues after peptide synthesis, including phosphorylation, acetylation, glycosylation, and methylation. Detected and characterized by tandem mass spectrometry.
The period during which a peptide maintains its specified purity, potency, and quality when stored under recommended conditions. Determined through stability testing programs.
Storage Stability CalculatorThe standard method for manufacturing synthetic peptides, where amino acids are added one at a time to a growing peptide chain anchored to an insoluble resin support.
A common reagent used in solid-phase peptide synthesis and HPLC purification. Residual TFA is a frequently tested contaminant and can form counterion salts with basic amino acid residues.
Contaminant TestingA peptide fragment that is shorter than the intended full-length sequence, typically resulting from incomplete synthesis or premature cleavage during manufacturing.
Send your peptide name, sample count, and the tests you need. We return a fixed-price quote, usually within one business day.
Now that you know the terminology, let our experts handle the testing. Get accurate results from an independent US lab.